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Abstract.  A  procedure is described to select mutants 
of Chinese hamster ovary cells that are conditionally 
defective for the cell-surface expression of integral 
membrane glycoproteins, including  the hemagglutinin 
(HA) of influenza virus.  Using a combination of cell 
sorting and biochemical screening,  seven cell lines 
were obtained that express more cell-surface HA at 
32°C than at 39°C.  The production of infectious vesic- 
ular stomatitis virus,  whose growth requires insertion 
of an integral  membrane protein into the plasma mem- 
brane,  was also temperature conditional in the 
majority of these mutant cell lines.  Five of the lines 
synthesized apparently normally core-glycosylated HA 
at the elevated temperature but the protein was neither 
displayed on the cell surface nor accumulated intracel- 
lularly.  In these cell lines,  little or no terminally gly- 
cosylated HA molecules were observed after synthesis 
at 39°C.  By contrast,  the core glycosylation of HA 
and several other integral membrane proteins was ab- 
normal in the remaining two cell lines at both permis- 
sive and restrictive temperatures,  due to a lesion in a 
cellular gene(s) that affects the formation of and/or the 
addition of mannose-rich oligosaccharide chains to 
newly synthesized polypeptides. Although HA was 
transported to the plasma membrane at both 32 and 
39°C,  it did not accumulate on the cell surface at the 
higher temperature,  apparently because of an increased 
rate of degradation. 
I 
N eukaryotic cells the  biosynthesis of membrane  and 
secretory proteins is coupled to the translocation  of the 
nascent polypeptide chains across the membrane of the 
rough ER (reviewed by Blobel, 1980; Sabatini et al.,  1982; 
Walter et al., 1984; Wickner and Lodish, 1985). Much prog- 
ress has been made in elucidating the mechanism of transfer 
of newly synthesized polypeptides to the luminal side of the 
ER (Siegel and Walter, 1985; Walter and Lingappa,  1986) 
and in defining various posttranslational  modifications  that 
occur as the proteins move from the ER, through the cister- 
nae of the Golgi apparatus,  to the plasma membrane or be- 
yond (Hubbard and Ivatt,  1981; Freedman,  1984; Kornfeld 
and Kornfeld,  1985; Bond and Butler,  1987). However, the 
mechanisms by which proteins destined for these locations 
are distinguished  from resident proteins of the ER and the 
Golgi apparatus are not fully understood. Studies of the sort- 
ing and transport of membrane and secretory proteins have 
focused on defining structural  features of the passenger pro- 
teins  that  govern  their  movement  through  the  exocytotic 
pathway  (Copeland  et  al.,  1986;  Garoff,  1985;  Gething, 
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1985; Gething et al., 1986; Kreis and Lodish, 1986). While 
potential signals have been identified for lysosomal (Sly and 
Fischer,  1982; Kornfeld and Kornfeld,  1985) and ER resi- 
dent proteins  (Munro and Pelham,  1987), relatively little is 
known about the cellular components involved in these pro- 
cesses. 
In mammalian  cells, the identification  of cellular  compo- 
nents involved in the synthesis,  modification,  and transport 
of nascent proteins  through  the secretory pathway has been 
approached  experimentally  in  three  ways. First,  in  vitro 
reconstitution  experiments  have been used to identify com- 
ponents involved in the cotranslational  transfer of secretory 
and transmembrane  proteins  to the luminal  side of the ER 
(Walter et al., 1984), or in the movement of the proteins from 
the ER to the Golgi apparatus  (Balch et al.,  1987; Beckers 
et al.,  1987), between Golgi cisternae  (Balch et al.,  1984; 
Braell  et  al.,  1984),  or  from  post-Golgi  vesicles  to  the 
plasma membrane (Woodman and Edwardson,  1986). Sec- 
ond, studies on passenger proteins  have in a few cases re- 
vealed cellular components involved in sorting steps. Thus, 
the formation of stable interactions between prefolded or ab- 
normally folded nascent glycoproteins  and the ER protein 
BiP (Haas and Wabl, 1984; Bole et al., 1986; Gething et al., 
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ER polypeptide egasyn (Tomino and Paigen, 1975; Lusis et 
al.,  1976),  or  between  mannose-6-phosphate-containing 
lysosomal hydrolases and the mannose-6-phosphate recep- 
tor(s) (Sahagian et al.,  1981; Hoflack and Kornfeld, 1985) 
have facilitated the identification and characterization of a 
few of the cellular components involved in the  secretory 
pathway. Finally, mammalian cell mutants have been isolated 
that display defects in the modification (reviewed by Stanley, 
1984) or export of membrane proteins (Trowbridge et al., 
1978; Kingsley and Krieger,  1984;  Kingsley et al.,  1986; 
Nakano et al.,  1985;  Tufaro et al.,  1987).  These studies 
have,  so far,  been limited in comparison to the extensive 
genetic analysis of the secretory pathway in Saccharomyces 
cerevisiae (Novick et al.,  1980; Ferro-Novick et al., 1984) 
which has defined at least 25 genes whose products are in- 
volved at discrete steps during the synthesis and transport of 
membrane and secretory proteins. 
To further elucidate the key steps in intracellular transport 
in mammalian cells, we have devised a new method for the 
isolation of cell lines carrying mutations in genes required 
for the synthesis and transport of integral membrane glyco- 
proteins.  This procedure uses a flow cytometer/cell sorter 
and a mammalian cell line that constitutively expresses large 
amounts on the cell surface of a well-characterized integral 
membrane glycoprotein, the influenza virus hemagglutinin 
(HA) ~ (Sambrook et al.,  1985).  This paper describes the 
isolation of several  mutant  2 cell lines that are temperature 
conditional for the cell-surface expression of HA and other 
integral  membrane  proteins.  In  the  accompanying paper 
(Hearing et al.,  1989),  two of these cell lines have been 
characterized in detail and evidence is presented for a defect 
in one or more cellular genes involved in the synthesis of the 
precursor oligosaccharide added to nascent secretory pro- 
teins in the ER. 
Materials and Methods 
Cells and Cell Culture 
Chinese hamster ovary (CHO) cells and their derivatives were maintained 
as described previously (Kozarsky et al., 1986) except that 10% FBS (Ar- 
mour Pharmaceutical Co., Kankakee, IL) was used. Cells were tested and 
found to be free of mycoplasma contamination (Chen,  1977).  The CHO- 
K1 cell line was obtained from J. Esko (University of Alabama, Binning- 
ham, AL). 
Derivation of the HA-CHO Cell Line 
HA-CHO cells were derived from CHO-KI as described previously for the 
production of HA-expressing murine cell lines (Sambrook et al.,  1985). 
Plasmid pBVI-MTHA (Sambrook et al.,  1985),  which contains a eDNA 
copy of the HA gene from the A/Japan/305/57 strain of influenza virus un- 
der the control of the murine metallothionein-I promoter, was transfected 
into CHO-K1 cells together with plasmid pON3 that contains the aminogly- 
coside phosphotransferase gene of Tn5. CHO cells expressing the bacterial 
gene were selected in medium containing 0.6 mg/ml G418 and colonies of 
resistant cells that expressed HA on the cell surface were identified by their 
ability to bind guinea pig erythrocytes (Sambrook et al., 1985).  Binding of 
1. Abbreviations  used in  this paper:  CHO, Chinese hamster ovary; HA, 
hemagglutinin; LDL,  low density lipoprotein; VSV,  vesicular stomatitis 
virus. 
2. The term mutant is used here to describe variant cell lines that differ in 
a stable fashion from the parental cell line although it is acknowledged that 
it has not been demonstrated that the observed phenotypes are the result of 
mutations. 
erythrocytes to HA-positive CHO cells was enhanced by treating the cells 
with  5  /tg/ml  L-l-chloro-3-[4-tosylamido]-4-phenyl-2-butanone-trypsin 
(TPCK-trypsin; Sigma Chemical Co., St. Louis, MO) for 15 rain at 37°C 
before the addition of erythrocytes. Several of these erythrocyte-binding 
clones were expanded and the amount of HA on the surface of the cells was 
examined by flow cytometry as described below.  Cells from the highest 
producing clone were sorted repeatedly for higher expression of cell-surface 
HA. After four sortings the cells were plated at low cell density and the 
resulting colonies screened for their ability to bind erythrocytes. One posi- 
tive clone (HA-CHO) was subjected to a final sort to obtain a population 
of cells that stably expressed high levels of HA on the plasma membrane. 
Mutagenesis 
HA-CHO  cells  were  mutagenized  by  exposure  to  500  #g/mi  ethyl 
methanesulfonate (Sigma Chemical Co.)  in growth medium for 18  h  at 
37°C.  The cells were grown at 32°C to allow mutations to become fixed 
within the genome and the mutant genes to be expressed. These mntagenesis 
conditions generally resulted in  10%  cell survival. 
Flow Cytofluorometry 
Expression of HA on the surface of cells was measured by quantitative flow 
cytofluorometry. The IgG fraction of a rabbit anti-HA serum (Gething et 
al., 1986) was purified by affinity chromatography (Ey et al., 1978) and con- 
jugated with FITC (isomer I; Sigma Chemical Co.) as previously described 
(Clark and  Shepard,  1963).  The fluorochrome/protein ratio of the con- 
jugated IgG (FITC-IgG) was 2.85 (Hudson and Hay, 1976). Cells were har- 
vested with 0.05%  trypsin (Gibco Laboratories, Grand Island, NY) and 0.5 
mM EDTA in PBS (136.9 mM NaCI, 2.7 mM KCI, 1.5 mM KH2PO4,  8.0 
mM Na2HPO4).  All subsequent manipulations were performed on ice with 
ice-cold FI2 medium containing FBS that had been heat inactivated at 56°C 
for 30 rain. Cells were washed once with F12 supplemented with 2% FBS 
and incubated for 30 rain with FrrC-IgG in the same buffer (200 td of a 
15 #g/rul solution per 106 cells). This amount of FITC-IgG was saturating; 
addition of more conjugated antibody caused an increase in the background 
fluorescence of HA-negative cells and did not significantly increase the level 
of specific fluorescence with HA-CHO cells. Unbound antibody was re- 
moved by gently washing the cells twice by resuspending the cells in ice- 
cold F12 containing 2% serum followed by pelleting at 200 g. Cells were 
finally resuspended in the same medium at  1-2  x  106 cells/ml, filtered 
through 3"/-#m nylon mesh (Small Parts, Inc., Miami, FL), and examined 
by flow cytomctry using a flow cytometer (Epics C; Coulter Electronics, Hi- 
aleah, FL) with a three-decade logarithmic amplifier in the green fluores- 
cence channel. Samples were excited with an argon ion laser (Coherent Inc., 
Worcester, MA) operating at 488 rim. All analytical cytofluorometric data 
presented were gated to remove cellular debris and small clumps of cells, 
and represent the results obtained from the analysis of 104 single cells. 
Clearance of Cell-surface HA 
HA was cleared from the plasma membrane of  HA-CHO cells by incubating 
cells on ice for 60 rain with sufficient nonfluorescent anti-HA IgG (350 ~g 
anti-HA  IgG  per  2  ×  106  HA-CHO  cells)  to  block  the  binding  of 
FITC-IgG. Excess IgG was removed by washing the cells with ice-cold FI2 
supplemented with 2 % heat-inactivated FBS. Cells were transferred to tis- 
sue culture plates containing F12 plus 10% heat-inactivated  FBS (prewarmed 
to 39°C) and incubated at 39°C for 16 h. 
Immunofluorescence 
The fate of "blocked" HA was examined by indirect immunofluorescence. 
Cells were treated with anti-HA IgG to remove cell surface HA as described 
above, incubated at 39°C for various periods and then incubated for 30 rain 
on ice with a  1:100 dilution of rhodamine-conjugated (IgG fraction) sheep 
anti-rabbit IgG (Cooper Biomedical, Inc., Malvern, PA) in F12 plus 2% 
heat-inactiva~l FBS. Cells were then washed with ice-cold F12 plus 2% 
heat-inactivated serum and fixed with 70% ethanol at 4°C for 16 h. Parallel 
samples were fixed with ethanol before incubation with the fluorescent anti- 
body.  Samples were mounted with  gelvatol  (Rodriguez and  Deinhardt, 
1960),  observed with a Dialux 22 EB microscope (E. Leitz, Inc., Rock- 
leigh, NJ), and photographed with a Vario-Orthomat 2 camera using Tri-X 
Pan film (Eastman Kodak Co., Rochester, NY). 
Radiolabeling of  HA and Immunoprecipitations 
Cells were seeded in 12-well multiwell trays (Flow Laboratories, McLean, 
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6-8 h at 320C.  Appropriate cultures were shifted to 390C and incubation 
was continued for 16 h. All media used for the in vivo labeling of  cells were 
prewarmed to either 32 or 390C. Cell monolayers were incubated at the ap- 
propriate temperature with labeling medium (methionine-free RPMI 1640 
[Gibco Laboratories] supplemented with 1.176 g/liter NaHCO3) for 30 min 
before labeling with [35S]methionine  (100 tzCi/well, >800 Ci/mmol; New 
England Nuclear, Boston, MA). Labeled cells were either transferred to ice 
and extracted (below) or washed with RPMI 1640 containing 10% FBS and 
incubated in this medium for further periods at the appropriate temperature. 
Cell extracts were prepared and immunoprecipitated as described previ- 
ously (Gething et al., 1986) except that precipitates were washed once with 
NET-Gel (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, pH Z5, 0.25% 
gelatin, 0.05%  Nonidet P-40) supplemented with 0.5 M  NaCI, once with 
NET-Gel supplemented with 0.1%  SDS and 1.0% Nonidet P-40,  and once 
with  10 mM Tris-HCl, pH Z5, 0.1%  Nonidet P-40. 
Primary glycosylation of HA was inhibited by incubating cells in growth 
medium containing 5/~g/ml tunicamycin (Calbiochem-Behring Corp., San 
Diego, CA) for 3  h before labeling. Tunicamycin was also present at the 
same concentration during preincubation in methionine-free medium and 
during labeling with [35S]methionine.  Sialic acid residues were removed 
from cell-surface proteins by washing the cells once with PBS and incubat- 
ing the cultures at 37°C in serum-free medium containing 0.5 U neuramini- 
dase (type V; Sigma Chemical Co.) during the last  15 min of the chase 
period. When desired, cell-surface HA was cleaved into HA1  and HA2 
subunits (White et al., 1982) with 15 #g/ml TPCK-treated trypsin in serum- 
free medium for 15 min at either 32 or 39°C. 
Analysis of the Expression of  Exogenous Viral 
Glycoproteins in ClIO Cell Lines 
Allantoic fluid from embryonated eggs infected with X31, a  recombinant 
influenza virus  bearing  the HA  from the A/Aichi/68  virus  (Kilbourne, 
1969), was provided by C. Copeland, Yale University Medical School, New 
Haven,  CT.  24  h  before the start of an experiment,  1  ×  105 cells were 
seeded per well of 24-well multiwell trays (Falcon Labware, Oxnard, CA) 
and incubated at 32°C.  16 h  before infection, appropriate cultures were 
shifted to 39°C. Virus adsorptions were performed in NaHCO3-free DME 
(Gibco Laboratories), 0.2% BSA, and 10 mM Hepes, pH 7.4,  for 60 min 
at room temperature. 100/zl of a 1:50 dilution of this allantoic fluid induced 
expression of HA on the surface of >95%  of CHO cells as judged by the 
binding of human erythrocytes at 6 h after infection. Infected cells were in- 
cubated at either 32 or 39°C in RPMI 1640 supplemented with 10% FBS. 
Where  indicated,  growth  medium containing  5  #g/ml  tunicamycin was 
added at 2.5 h after infection. Proteins were radiolabeled with [35S]methio- 
nine at 5 h after infection  and extracte.d,  as described above. Immunoprecipi- 
tations were performed using a rabbit antiserum that recognizes X31  HA 
but not the endogenous Japan HA synthesized in HA-CHO cells. 
Cells to be infected with vesicular stomatitis virus (VSV, Indiana sero- 
type, San Juan strain) were seeded either in 12-well multiwell trays at 1 x 
105 cells per well or in 60-mm plates at 5  x  105 cells per plate and in- 
cubated at 32°C for 6-8 h. Appropriate cultures were shifted to 39°C and 
incubation continued for  14-16  h.  Cells were infected with  10  plaque- 
forming units/cell of VSV in PBS supplemented with 2% FBS. Adsorptions 
were carried out for 45 min at room temperature. Infected cells were in- 
cubated in RPMI 1640 supplemented with 10% FBS at 32 or 39°C and ra- 
diolabeled with [35S]methionine  between 3-4 h after infection. Radiolabel- 
ings, preparation of  cell lysates, and immunoprecipitations were performed 
as described above for analysis of HA. VSV G glycoprotein was immuno- 
precipitated using a rabbit antiserum provided by M.  Roth (University of 
Texas  Southwestern Medical Center, Dallas, TX). 
The ability of VSV to grow in parental and mutant CHO cell lines was 
compared by infecting cultures (1  x  105 cells per well of Linhro 12-well 
multiwell trays) at 32 or 39°C with 10 plaque-forming units/cell of VSV. 
Infected cultures were incubated at the appropriate temperature for 8 h and 
the number of infectious particles in the culture medium was determined 
by plaque formation on confluent CHO cultures. Plaque assays were per- 
formed at 32°C with RPMI  1640  medium containing 5%  FBS and 0.8% 
Noble agar. 
Analysis of the Expression of the Low Density 
Lipoprotein (LDL) Receptor in CHO Cell Lines 
The LDL receptor was immunoprecipitated from detergent lysates of  paren- 
tal and mutant cells by a modification of the procedure of Tolleshaug et al. 
(1982).  Cells were  seeded at  1  ×  106  cells per  10-cm dish in growth 
medium and incubated at 320C  for 8  h.  At this time the cultures were 
washed twice with PBS, fresh growth medium containing 10% lipoprotein- 
poor serum (the generous gift of D.  Russell, University of Texas  South- 
western Medical Center) prewarmed to 390C was added, and the cultures 
were incubated for 16 h at 39°C. Duplicate cultures were starved for 20 min 
in methionine-free medium and then pulse-labeled for 60 min at 39°C with 
100/~Ci/rnl  [35S]methionine  in methionine-free medium.  One plate was 
immediately extracted while the second was washed and incubated for 120 
rain with medium contaifiing nonradioactive methionine. The cultures were 
washed once with ice-cold PBS and cell extracts were prepared as previ- 
ously described (Tolleshaug et al., 1982).  The LDL receptor was immuno- 
precipitated with immune complexes formed between a rabbit serum raised 
against a carboxy-terminal peptide of the receptor that is highly conserved 
between species (a generous gift of D. Russell) and goat anti-rabbit IgG an- 
tibodies (Cappel Laboratories, Cochranville, PA).  The conditions for the 
formation  and  washing  of  immunoprecipitates  have  been  described 
(Tolleshaug et al.,  1982).  Immunoprecipitated proteins were analyzed by 
electrophoresis on a 7.5%  SDS-polyacrylamide gel followed by fluorogra- 
phy and autoradiography. 
Results 
Isolation and Properties of the Parental 
HA-CHO Cell Line 
The parental cell line constructed for these experiments was 
a CHO cell line that constitutively expresses influenza virus 
HA  on  the  cell  surface  (see  Materials  and  Methods). 
HA-CHO cells, which are readily distinguishable from HA- 
negative CHO cells by flow cytofluorometric analysis of HA 
present on the cell surface (Fig.  1),  express an average of 
106 molecules of HA per cell, as determined by radioim- 
munoassay (Gething and Sambrook, 1981; our unpublished 
results) and can be passaged continuously for 3 mo without 
a detectable change in the level of expression of HA on the 
cell surface as measured by flow cytofluorometry. Nucleic 
acid  hybridization  experiments  (Sambrook  et  al.,  1985) 
demonstrated that the cells contain ,v300 integrated copies 
of the HA gene (data not shown). In addition to increasing 
Figure  1.  Flow  cytofluorometric  analysis  of HA  expression  on 
HA-CHO  cells.  CHO  cells  (top)  and  HA-CHO  cells  (bottom) 
growing at 37°C were labeled with FITC-conjugated anti-HA IgG 
and the amount of antibody bound per cell was determined by quan- 
titative  cytofluorometry  as  described  in  Materials  and  Methods. 
Each histogram represents the analysis of 104 cells.  The data are 
presented as log green fluorescence (LGFL), on an arbitrary three- 
decade log scale, vs. cell number. HA-CHO cells express, on the 
average,  106 molecules HA per cell (unpublished data). 
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of the  HA gene decreases  the possibility of selecting cell 
lines that suffer mutations in the gene for this glycoprotein 
rather than in cellular genes. 
The procedure developed to isolate cellular mutants with 
defects in the exocytotic pathway  (see below) involves the 
physical separation  (sorting)  from mutagenized  HA-CHO 
cultures of cells that are defective for the display of HA on 
the  plasma membrane.  The  success  of this  procedure de- 
pends on (a) efficient removal of HA that is already present 
on the plasma membrane at the time of the shift to the restric- 
tive temperature,  and  (b) efficient repopulation of the cell 
surface of nonmutant cells with newly synthesized HA at this 
restrictive temperature. Cell-surface HA cannot be removed 
by digestion with trypsin or proteinase K (results, not shown) 
even after induction ofa conformational change in HA by ex- 
posure to low pH (Skehel et al., 1982). However, incubation 
of HA-CHO cells with excess anti-HA IgG reduced their 
ability to bind FITC-conjugated anti-HA IgG (Fig. 2, B and 
C).  The  plasma membranes of the  antibody-treated HA- 
CHO cells could be repopulated with HA during an 18-h in- 
cubation at either 32 or 39°C  (Fig.  2,  D  and E). 
The fate of the cell-surface HA after the treatment with 
excess  antibody  was  investigated  by  immunofluorescence 
studies (Fig. 3) and immunoprecipitation experiments (Fig. 
4). HA-CHO cells incubated in the absence of anti-HA IgG, 
fixed with ethanol, and stained for the presence of HA dis- 
played a diffuse surface fluorescence as well as a small num- 
ber of discrete local areas of greater intensity (Fig. 3 1). This 
pattern of fluorescence did not change during 120 min of in- 
cubation at 39°C  (Fig.  3 J).  By contrast,  HA-CHO cells 
treated with excess anti-HA IgG displayed punctate surface 
fluorescence (Fig. 3 C). This patching of HA on the plasma 
membrane was reminiscent of the aggregation of surface im- 
munoglobulin on B ceils induced by antiirnmunoglobulin an- 
tibody (Taylor et al.,  1971; Unanue et al.,  1972).  A similar 
pattern was observed when HA-CHO cells were fixed before 
labeling with the fluorescent antibody (compare Fig.  3,  C 
and D) demonstrating that the redistribution of surface HA 
was due to binding of the anti-HA IgG. Incubation of the 
IgG-treated HA-CHO cells for 15 min at 39°C  resulted in 
a dramatic decrease in the amount of HA-IgG complexes on 
the cell surface (Fig.  3  E)  although they were present in- 
traceUularly at this time (Fig. 3 F). No HA-IgG complexes 
could be detected on the plasma membrane after incubation 
for 120 min at 39°C (Fig. 3 G) and the amount of complexes 
inside the cells was greatly reduced (Fig. 3 H). These data 
are consistent with antibody-induced patching of cell-surface 
HA followed by rapid internalization of HA antibody com- 
plexes into endocytic vesicles. To exclude the possibility that 
the complexes dissociate within the cell allowing HA to re- 
turn to the cell surface, HA-CHO cells were radiolabeled 
Figure 2.  Blocking of FITC-IgG binding and reexpression of HA 
on the surface of HA-CHO cells. HA-CHO cells were incubated 
with saturating amounts of anti-HA IgG (Materials and Methods) 
and the amount of FITC-IgG that was able to bind to the cells was 
tested immediately (C) or after an 18-h incubation at 32°C (D) or 
39°C  (E)  by  flow cytofluorometry.  The  nonspecific  binding  of 
FITC-IgG  to CHO cells (A) and specific binding to HA-CHO cells 
growing at 32°C (B) are also shown. The cytofluorometry data are 
presented as in Fig.  1. 
with [3sS]methionine and incubated for 4 h at 37°C to allow 
labeled HA to reach the plasma membrane. Cell-surface HA 
was cleaved with trypsin into its component HA1 and HA2 
subunits  (White  et al.,  1982;  Sambrook et al.,  1985)  and 
then the ceils were incubated in the presence or absence of 
anti-HA IgG and incubated for 16 h at 39°C. After the incu- 
bation, no HAl  or HA2 species could be detected in cells 
treated with the  antibody  (Fig.  4,  lane  6).  By contrast,  a 
significant amount of these species was still present in the 
control cells (Fig. 4, lane 4). These data demonstrate that the 
internalized HA was degraded during the 16-h incubation at 
39°C. 
Figure 3. Removal of HA from the surface of HA-CHO cells treated with anti-HA antibody. CHO and HA-CHO cells were treated with 
saturating amounts of rabbit anti-HA IgG and incubated at 39°C for 0, 15, or 120 min. These cells were either stained with rhodamine- 
conjugated sheep anti-rabbit IgG to detect HA-IgG complexes on the cell surface (A, C, E, and G) or fixed with ethanol before labeling 
with the fluorescent antibody to detect both surface and intracellular HA-IgG complexes (B, D, F, and H). As a control,  HA-CHO cells 
not treated with anti-HA IgG were incubated at 39°C for 0 (I) or 120 min (J) and subsequently stained for the presence of surface and 
intracellular HA. (A and B) CHO cells, 0 min. (C and D) HA-CHO cells, 0 rain. (E and F) HA-CHO cells, 15 min. (G and H) HA-CHO 
cells,  120 min. 
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CHO ceils with anti-HA IgG. HA-CHO cells were labeled for 60 
rain with [35S]methionine,  as described in Materials and Methods, 
and then incubated with medium containing nonradioactive methio- 
nine for 4 h before treatment with trypsin to cleave cell surface HA 
into HA1 and HA2 subunits. The cells were then treated with anti- 
HA IgG (lanes 5 and 6) or mock-treated (lanes 3 and 4). Cell ex- 
tracts were either prepared immediately (lanes 3 and 5) or after a 
16-h incubation at 39"C (lanes 4 and 6). HA was immunopreeipi- 
tated using further addition of antibody and displayed on a 10% 
SDS-polyacrylamide gel. Control immunoprecipitates of  CHO cell 
extracts are shown in lanes 2 and Z Molecular mass markers are 
shown in lanes 1 and 8. The HA species whose positions are indi- 
cated on the left are core-glycosylated and terminally glycosylated 
uncleaved HA (HAt) and the trypsin-cleavage products of termi- 
nally glycosylated HAt (HA/and HA,?,). 
Isolation of  Secretory Pathway Mutants 
The procedure developed to isolate cellular mutants with 
defects in the exocytotic  pathway is summarized in Fig. 5. To 
permit the isolation of mutants carrying defects in essential 
cellular genes,  and to exclude mutants that are generally 
defective for the synthesis of HA, the selection procedure 
was designed to isolate temperature-conditional mutants. In- 
dependently  mutagenized  populations  of HA-CHO  cells 
were grown at 32°C for 7-10 d to allow mutations to become 
fixed in the genome and the mutant genes to be expressed. 
The cells were then incubated at the restrictive temperature, 
39°C, for 4 h to allow HA molecules already in transit along 
the secretory pathway to reach the plasma membrane. HA 
was then cleared from the cell surface by endocytosis after 
capping with excess antibody and cells that were unable to 
repopulate the plasma  membrane with HA at 390C were 
selected using a cell sorter. These cells were then returned 
to the permissive temperature, 32°C, for further growth. Be- 
cause the sorted fraction contained some wild-type cells it 
was  further enriched for mutants by additional rounds of 
negative selection (sorting). Ceils that expressed cell-surface 
HA at 32°C were then separated by a round of positive selec- 
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t 
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Est.~11sh cult.ures  at 32°C 
t 
Remove HA frm  cell  surface 
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t 
t 
Clo~ colls at 32°1: 
t 
Scre~ for socreto~ patlm~ mtmts 
by biodmnica|  mml]rsts 
Figure 5. Protocol for the selection of mammalian cell secretory 
pathway mutams. Details of  the selection procedure are given in the 
Materials and Methods and Results sections. 
tion from those cells that had lost the ability to express HA 
at either temperature. These cells were then subjected to a 
final round of sorting for HA-negative cells at  39°C  and 
cloned to provide individual cell lines. 
Multiple clones from each mutagenized population (a total 
of 46 clones from 10 independently mutagenized cultures) 
were screened by pulse-chase radiolabeling for the ability to 
synthesize and transport HA to the cell surface at 32 and 
39°C.  Cells  were labeled with  [35S]methionine,  incubated 
for 2-3 h in medium containing nonradioactive methionine, 
and treated with low levels of trypsin to cleave any labeled 
HA that had been transported to the cell surface into HA1 
and HA2 subunits. Cell lysates were then prepared and HA 
molecules were immunoprecipitated with anti-HA  serum 
and separated by SDS-PAGE. The majority of the clones ex- 
pressed low levels of HA atboth temperatures and displayed 
no obvious temperature-conditional defects in the modifica- 
tion or transport of  the HA molecule. However, five cell lines 
(clones 1A, 3A, 4E, 4F, and 41) were defective in their ability 
to display HA on the cell surface at the restrictive tempera- 
ture, as evidenced by the presence of core-glycosylated but 
not terminally glycosylated HAO and/or the absence of HA1 
and HA2 species (see for example Fig.  7  for results with 
clones 3A and 4E). Two additional cell lines (clones 4B and 
4J) expressed aberrant forms of HA (see below, Fig. 8). To 
rule out the possibility that the polypeptide backbone of HA 
was altered in these mutants,  we compared the molecular 
weights of the nonglycosylated  form of HA synthesized after 
treatment Of the parental or mutant cells with tunicamycin 
(Takasuld et al.,  1975). No difference was observed in the 
mobility of the HA polypeptides on SDS-polyacrylamide 
gels (see for example the data shown in Figs.  7  and 8 for 
clones 4E, 413, and 4J). Of the seven cell lines, six were de- 
rived from independently mutated populations,  while  the 
seventh, clone 1A, displayed a distinct flow cytometry pat- 
tern (see below) from clone 3A which arose from the same 
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once more and examined further as described below. 
Analysis of the Mutant Cell Lines by Flow Cytometry 
The seven mutant cell lines were analyzed by flow cytometry 
for reexpression of HA on their plasma  membranes after 
treatment with anti-HA IgG. The results obtained with the 
parental HA-CHO cells and five representative clones iso- 
lated from independently mutagenized cultures are shown in 
Fig. 6. In this experiment cells were shifted to 39°C for 18 h 
then returned to 32°C for 24 h without treatment (Fig. 6 A), 
or treated with anti-HA IgG and then incubated for 24 h at 
32 or 39°C (Fig. 6, B and C). There was significant variation 
between the different clones in the amount of HA displayed 
on the cell surface after growth at the permissive tempera- 
ture. The majority of  the clones expressed somewhat less HA 
than  the parental  HA-CHO  cells,  but one (clone 4J)  ex- 
pressed significantly higher amounts of HA (see also Fig. 8). 
This variation may be due to a change in the number of in- 
tegrated HA genes, in the level of synthesis of HA, in the rate 
of turnover of newly synthesized HA, or a combination of 
these factors.  All the clones displayed temperature-depen- 
dent defects in reexpression of HA at the cell surface, al- 
though the severity of these defects varied from mutant to 
mutant. After removal of cell-surface HA and incubation for 
24 h at 32°C, all the mutant cell lines were able to reexpress 
HA on the plasma membrane, albeit at reduced levels com- 
pared to the untreated controls. Incubation for 48 h was re- 
Figure 6. Cell-surface expression of HA in HA-CHO cells and mu- 
tant cell lines. The level of HA on the surface of HA-CHO cells 
and five mutant cell lines was determined by flow cytofluorometry. 
The data are presented as described in Fig. 1. (A) Cells growing at 
32°C with no prior treatment; (B and C) cells treated with anti-HA 
IgG and then incubated for 24 h at 32 (B) or 39°C  (C) before 
analysis. 
quired for full repopulation of the surface of the mutant cells 
(results not shown).  However, at 39°C each of the mutant 
clones was markedly defective in the ability to express HA 
on the cell surface. Clones 4B and 4E were the most severely 
affected at the restrictive temperature,  with an essentially 
complete blockage of expression of HA on the plasma mem- 
brane. These two clones also expressed relatively low levels 
of cell-surface HA during growth at 32°C.  The results ob- 
tained with clones 1A and 4I, which are not shown in Fig. 
6, closely resembled those shown for clone 4E. 
Only Clones 4J and 4B Are Temperature Conditional 
for Growth 
We next tested the growth characteristics of the cells at the 
elevated temperature. The growth rates and plating efficien- 
cies at 39°C of clones 1A, 3A, 4E, 4F, and 4I were approxi- 
mately the same as those of the parental cells, although occa- 
sional small colonies of the mutant cells were observed at 
this temperature. However, the results shown in Table I dem- 
onstrate that clone 4B and 4J cells are temperature condi- 
tional for growth. Clone 4B was unable to form colonies at 
39°C even when plated at a density of 1@ cells per 10-cm 
dish.  Clone 4J  failed to grow when  1@ cells were plated 
per dish,  although when  10  ~ cells were seeded significant 
growth was  obtained yielding ,x,120 discrete colonies and 
many smaller, diffuse colonies. When the ability of cells de- 
rived from 20 of these colonies to grow at 39°C was inves- 
tigated, they were found to be defective for growth at low cell 
density at 39°C, suggesting that cell-cell interactions occur- 
ring  at  the  higher density  allowed growth  to  occur.  The 
growth defect at 39°C may be due to the inability of plasma 
membrane  proteins  to  accumulate  at  the  cell  surface  in 
sufficient quantities to perform essential functions. Despite 
this growth defect, clone 4B and 4J cells plated at the permis- 
sive temperature were still viable after an extended incuba- 
tion at the restrictive temperature; during the original selec- 
tion  procedure  mutant  4B  and  4J  cells  sorted  by  flow 
cytometry after incubation for 24 h at 39°C plated efficiently 
at  32°C.  Furthermore,  after  a  16-h  incubation  at  39°C, 
[35S]methionine  was incorporated into protein in clone 4B 
and 4J cells in amounts similar to the other cell lines (results 
not shown). 
Defective Growth of VSV in the Mutant Cell Lines 
To confirm that the defective transport of HA to the plasma 
membrane in the seven cell lines was a consequence of a mu- 
tation in a gene encoding some essentia~ cellular component 
Table L  Effect of Cell Density  Upon the Growth of the 
Mutant  Cell Lines 4B and 4J at 39°C 
Number of cells seeded* 
Cell line  10  4  10  ~  106 
HA-CHO  +  +  + 
clone 4B  -  -  - 
clone 4J*  -  -  - 
* The indicated number of cells were seeded per 10-cm dish in duplicate and 
then  incubated  at  39"C  for  10  d.  At  that  time  the  cells  were fixed  with 
methanol, stained with Giemsa, and the number of colonies quantitated.  +, 
Efficient colony formation;  -,  no cell growth. 
t  Approximately 120 colonies per dish. 
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their ability to support the propagation of VSV. The assem- 
bly  of infectious VSV  particles  requires  the  presence of 
newly synthesized G protein in the plasma membrane (Lafay, 
1974; Knipe et al.,  1977) and the ability of VSV to grow in 
various cell lines has been used as a test of the capability of 
the cells to synthesize and transport G protein to the cell sur- 
face (Gibson et al.,  1981; Schlesinger et al.,  1984; Nakano 
et al., 1985; Tufaro et al.,  1987). The growth of VSV in the 
parental HA-CHO cells was four- to sevenfold lower at 39°C 
compared to 32°C (Table II). While the yield of virus from 
mutant clones 4E and 4F was only slightly reduced from that 
observed with HA-CHO cells, clones 1A, 3A, 4B, 41, and 
4J were markedly temperature conditional for virus growth. 
These results are consistent with the presence in these mu- 
tant cells of defects in the cellular components involved in 
the synthesis, modification, or transport of VSV G protein 
to the plasma membrane. 
Analysis of the Intracellular Transport of HA in the 
Mutant Cell Lines 
Mannose-rich oligosaccharides are added as preformed units 
to newly synthesized secretory proteins in the ER.  These 
side chains are then modified by the removal and subsequent 
addition of sugar residues, beginning in the ER and continu- 
ing as the glycoproteins traverse the compartments of the 
Golgi  apparatus  (Hubbard  and  Ivatt,  1981; Kornfeld and 
Kornfeld, 1985). The synthesis of core-glycosylated HA and 
its  conversion to the  terminally  glycosylated form  in  the 
seven mutant cell lines was investigated at the permissive and 
Table I1.  Growth of VSV in Parental and Mutant 
Cell Lines* 
Cell line  32°C  yield¢  39°C yield  32°C/39°C§ 
Experiment 1 
HA-CHO  7.7  x  105  1.5  x  105  5 
clone 4B  3.0  x  106  2.4  x  104  125 
clone 4J  3.6  x  10  ~  1.5  x  104  24 
clone 3A  4.5  x  106  1.1  x  105  41 
clone 4E  8.0  ×  105  1.1  ×  105  7 
Experiment 2 
HA-CHO  1.0  x  106  1.4  ×  105  7 
clone 4B  8.6  x  105  4.5  x  103  191 
clone 4J  2.0  ×  105  1.5  ×  103  154 
clone 3A  6.5  x  106  1.1  x  105  59 
clone 4E  3.5  x  105  1.0  ×  105  9 
Experiment 3 
HA-CHO  6.5  x  105  1.7  x  105  4 
clone 1A  9.5  x  105  1.6  x  104  59 
clone 4F  9.2  x  105  2.7  ×  105  3 
clone 4I  3.7  ×  105  2.7  x  104  14 
Experiment 4 
HA-CHO  1.6  ×  104  2.5  x  105  6 
clone 1A  9.9  x  106  2.1  x  105  47 
clone 4F  6.1  x  106  5.0  ×  105  12 
clone 41  1.1  x  104  4.9  ×  104  22 
* The ability of VSV to grow in HA-CHO cells and mutant cell lines was de- 
termined as described  in Materials and Methods. 
;t Virus yields are presented  as plaque-forming  units per ml. 
§ The ratio of virus yield at 32°C to that at 39°C  is shown. 
restrictive  temperatures  using  pulse-chase  labeling  pro- 
tocols. 
Five of the cell lines displayed decreased terminal glycosy- 
lation and increased turnover of HA at the restrictive temper- 
ature, although there was some variation in the severity of 
the phenotype. Examples of the data obtained with two rep- 
resentative cell lines, clone 3A and clone 4E, are shown in 
Fig. 7.  Core-glycosylated HA synthesized in parental HA- 
CHO cells at 32°C  during a  30-min labeling period with 
[35S]methionine migrated on SDS-polyacrylamide gels with 
an apparent molecular mass of 68 kD (Fig. 7, A and B). Ap- 
proximately 50% of these molecules were converted to the 
~74-kD  terminally glycosylated form during  a  2-h chase 
period, while the remaining 50% had undergone trimming 
of mannose residues to yield an ~66-kD form of HA (Fig. 
7 A). At the end ofa 4-h chase, the majority of the HA mole- 
cules in the parental HA-CHO cells had been converted to 
the terminally glycosylated form (Fig.  7 B).  Very similar 
results were obtained at 39°C, although there was some in- 
crease in the turnover of the labeled HA molecules. The HA 
species synthesized in clone 4E and 3A cells during a 30-min 
pulse  with  [35S]methionine  at  32  or  39°C  also  migrated 
with an apparent molecular mass of 68 kD (Fig. 7, A and B), 
indicating  that  there  was  no  obvious  defect  in  the  core 
glycosylation of the HA polypeptide in these cells. During 
the chase period at 32°C, HA was converted to the terminally 
glycosylated form in both mutant cell lines, and inspection 
of autoradiographs exposed for different times showed that 
the extent of conversion was comparable to that in the paren- 
tal HA-CHO cells (Fig. 7, A and B). In both clone 4E and 
3A cell lines, labeling at 39°C resulted in the incorporation 
into HA of  amounts of radioactivity similar to those observed 
at 32°C, confirming that protein synthesis is not defective at 
the  restrictive temperature.  However, during  a  2-h  chase 
period at 39°C there was significant turnover (>50%) of the 
HA in clone 4E ceils, while there was little or no loss of la- 
beled HA in HA-CHO cells chased for the same period at 
the restrictive temperature. After the chase very little HA in 
clone 4E cells was  present in the terminally glycosylated 
form, although the residual core-glycosylated  molecules had 
undergone trimming of the oligosaccharide side chains (Fig. 
7 A). Increased turnover of HA at the restrictive temperature 
was also observed in clone 3A cells, and no HA species could 
be detected after a 4-h chase at 39°C (Fig. 7 B). 
Strikingly different results were obtained when similar ex- 
periments were performed with clones 4B and 4J (Fig. 8). 
HA synthesized in these mutant cell lines at either the per- 
missive  or  the  restrictive temperature during  the  30-min 
labeling period was heterogeneous in size. Some of the la- 
beled HA molecules migrated with approximately the same 
electrophoretic mobility as  core-glycosylated HA  synthe- 
sized  in  the  parental  HA-CHO  cells,  but  the  majority 
migrated as a broad band with significantly increased mobil- 
ity (Fig. 8 A). The electrophoretic mobility of nonglycosy- 
lated HA synthesized at either temperature in clone 4B, 4J, 
or the parental HA-CHO cells was indistinguishable (Fig. 8 
B), indicating that the altered mobility of HA synthesized in 
the mutant cells was due to aberrant glycosylation, rather 
than to a change in the polypeptide backbone of HA. The 
aberrant forms of HA detected in clone 4B and 4J cells after 
the 30-min labeling period were observed at both 32  and 
39°C (Fig. 8 A), suggesting that the glycosylation defect in 
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modification of HA in HA-CHO cells and 
clones 4E and 3A. Cells were pulse-labeled 
with [35S]methionine for 30 min in the pres- 
ence (T) or absence (P) of tunicamycin and 
extracted immediately or chased for 2 (A) or 
4 h  (B)  in the presence  of nonradioactive 
methionine  (C).  The  pulse-chase  experi- 
ment was performed at both 32 and 39°C as 
described  in Materials  and  Methods.  HA 
was immunoprecipitated  from the cell ex- 
tracts and analyzed  by electrophoresis  through 
10%  SDS-polyacrylamide  gels.  (M)  ~4C 
molecular mass markers. 
these cells is not temperature conditional. An additional pro- 
tein that migrates as a  very sharp band of molecular mass 
'~77 kD coprecipitated with HA from extracts of mutant cells 
labeled at 39°C, but was present in reduced amounts or ab- 
sent from immunoprecipitates of cells labeled at 32°C. Sepa- 
rate immunoprecipitation experiments (not shown) identified 
this polypeptide as BiP,  the immunoglobulin heavy chain- 
binding  protein  (Bole et  al.,  1986;  Gething  et  al.,  1986) 
which has been shown to associate with unfolded molecules 
of HA in the ER (Gething et al.,  1986). 
The aberrant migration of HA observed after the 30-min 
pulse  with  [35S]methionine  (Fig.  8  A)  was  also  observed 
when 4J cells were labeled for a  period as short as 5  min 
(data not shown).  Studies on the biosynthesis and folding of 
HA in HA-CHO cells have demonstrated that at this time af- 
ter synthesis the nascent HA molecules are monomeric and 
restricted  to the  ER  (Hearing et al.,  1989,  accompanying 
manuscript). The HA molecules have received mannose-rich 
core oligosaccharide side chains but these side chains have 
not  yet  undergone  extensive  trimming  or  modification. 
These data are consistent with the aberrant mobility of HA 
molecules synthesized in the mutant cells being the result of 
addition of abnormal core oligosaccharide units to the na- 
scent HA polypeptide chains. 
By contrast to parental HA-CHO cells, significantly less 
(50-75 %)  of the  labeled  HA molecules  synthesized  in  4J 
cells were converted to a higher molecular mass form during 
the chase period at 32 or 39°C (Fig.  8 A). The data suggest 
that the oligosaccharide side chains on the HA molecules in 
clone 4J cells are processed more extensively at the lower 
temperature, since at 32°C the higher molecular mass band 
migrated more slowly than the terminally glycosylated HA 
in the parental cells, while at 39°C there was little difference 
in the mobilities of the terminally glycosylated molecules in 
clone 4J and HA-CHO cells (Fig.  8, A and D). At both 32 
and 39°C there was significant loss of labeled HA in 4J cells 
during the chase period (Fig. 8 A). Less HA was synthesized 
in clone 4B cells at both temperatures (Fig.  8, A and B; see 
also Fig. 6), perhaps because of deletion of integrated copies 
of the HA gene rather than a  generalized defect in protein 
synthesis since these cells express exogenous viral glycopro- 
teins at levels equivalent to clone 4J or HA-CHO cells (see 
below Figs. 9 and 10). The labeled HA in clone 4B cells was 
rapidly lost during the chase periods (Fig.  8 A). 
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modification of HA in HA-CHO, clone 4J, and clone 4B ceils was examined as described in the legend to Fig. 7, using a 4-h chase period. 
The gel containing HA immunoprecipitated from cells labeled at 39°C was exposed longer to film to reveal HA molecules synthesized 
in clone 4B cells. (B) The synthesis of nonglycosylated HA in the three cell lines was examined by labeling cells treated with tunicamycin 
with [35S]methionine  for 30 min as described in Materials and Methods.  HA was immunoprecipitated from cell extracts and displayed 
on a 10% SDS-polyacrylamide gel. The experiment was performed at both 32 and 39°C. (C) Cells were labeled for 17 h with [3sS]methi- 
onine at either 32 or 39°C. HA accessible at the cell surface at the end of this labeling period was reaved with trypsin and then cell extracts 
were prepared. After immunoprecipitation, the HA species were displayed on a  12%  SDS-polyacrylamide gel.  (D) The expression of 
HA on the plasma membrane of HA-CHO and clone 4J cells at 32 and 39°C was assayed by labeling the cells for 30 min with [35S]methi- 
onine, incubating them for 4 h in medium containing nonradioactive methionine, and then treating them with (+) or without (-) neuramini- 
dase during  the  last  15-min chase period.  HA molecules were  immunoprecipitated and  analyzed by electrophoresis through  a  10% 
SDS-polyacrylamide gel. 
HA Synthesized in Clone 4.I and 4B Cells Reaches the 
Cell Surface and is Rapidly Degraded 
The results  shown in Fig.  8 A indicate that a proportion  of 
the  pulse-labeled  HA  molecules  in  clone  4J  cells  pass 
through  the  cisternae  of  the  Golgi  apparatus  where  the 
oligosaccharide  side chains  are modified to more complex 
forms. The susceptibility of these molecules to treatment of 
intact cells with  neuraminidase  (Fig.  8  D) or trypsin  (data 
not shown) demonstrated that they contained sialic acid and 
had been transported to the cell surface. The lower molecular 
mass forms of HA in 4J cells were not affected by the en- 
zymes,  consistent  with  their remaining  intracellularly  in a 
pre-Golgi compartment. Since this cell line had been selected 
on the basis of temperature-conditional expression of HA on 
the plasma membrane, we wished to determine whether the 
low steady-state level of HA measured by flow cytometry was 
due to rapid turnover of the aberrantly glycosylated HA dur- 
ing growth at 39°C.  HA-CHO, 4J or 4B cells were labeled 
continuously  with  [35S]methionine  for  17  h  at 32  or  39°C 
and then the intact cells were treated with trypsin (15 ~g/ml) 
for 15  rain before cell extracts were prepared,  precipitated 
with anti-HA serum, and fractionated by electrophoresis on 
SDS-polyacrylamide gels. The great majority of the labeled 
HA in the parental cell line was cleaved into HA1 and HA2 
subunits,  indicating  that it  was present  on the cell  surface 
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of core-glycosylated and terminally glycosylated HAO re- 
mained inaccessible to trypsin, while at 39°C only trace 
amounts of terminally glycosylated HA remained within the 
cells. Although the rate of incorporation of [35S]methionine 
into HA in clone 4J cells is higher than that in the parental 
cells (Fig. 8, A, B, and D), greatly reduced amounts of the 
radiolabeled HA  species  were present after the  extended 
labeling period at 32°C, and only trace amounts of labeled 
HA were detected after synthesis at 39°C (Fig. 8 C). The 
residual HAO molecules showed a pattern of aberrant gly- 
cosylation identical to that seen in the shorter term pulse- 
chase experiments,  and as previously observed,  only the 
higher molecular mass, terminally glycosylated species was 
transferred to the cell surface where it was accessible to tryp- 
sin (Fig. 8 C) or neuraminidase (Fig. 8 D). No HA species 
were detected in extracts of clone 4B cells labeled at either 
temperature (Fig. 8 C). Taken together, the results shown in 
Fig. 8 confirm that aberrantly glycosylated HA molecules 
are synthesized in clone 4B and 4J cells at both the permis- 
sive and the restricted temperature. In clone 4J cells, a sig- 
nificant proportion of these HA molecules reach the cell sur- 
face but they are apparently turned over at a higher rate than 
the normally glycosylated HA molecules synthesized in the 
parental HA-CHO cells. Sufficient HA accumulates on the 
surface of clone 4B or 4J cells during growth at 32°C for 
them to be included in the sort for HA-positive cells that was 
a step in the mutant selection procedure (Fig. 5). However, 
the rate of turnover of HA in clone 4B and 4J cells is much 
higher at 39°C than at 32°C (Fig. 8 C) so that the steady-state 
level of HA on the surface of the mutant cells is low enough 
for them to be included in the HA-negative population upon 
sorting after incubation at 39°C. 
Clones 4B and 4J Display Generalized 
Glycosylation Defects 
To determine if the glycosylation defect(s) in clones 4B and 
4J were specific for the endogenous Japan HA or if other 
exocytotic proteins were also affected, cells were infected 
with a recombinant influenza virus (X31) that encodes an HA 
which does not cross-react serologically with the Japan HA 
(see Fig. 9, uninfected extracts, lanes 1, 8, and 15) or with 
VSV, and the biosynthesis of  the viral glycoproteins was ana- 
lyzed. In addition, we examined the processing and transport 
of a  cellular  integral  membrane  glycoprotein,  the  LDL 
receptor. 
HA-CHO, 4J or 4B cells growing at 32 or 39°C were in- 
fected with X31 virus for 2.5 h, incubated for 2.5 h in the 
presence or absence of tunicamycin, and then pulse-labeled 
for 30  min with [35S]methionlne.  A  serum raised against 
disrupted X31  virions precipitated viral proteins from ex- 
tracts of  infected cells (Fig. 9). Greater amounts of these pro- 
teins were synthesized at 39°C than at 32°C.  The 58-kD 
influenza virus nucleocapsid protein was present in all in- 
fected cells and, as expected, the mobility of  this polypeptide 
was not affected by treatment of the cells with tunlcamycin. 
In addition, the serum precipitated the 61-kD nonglycosy- 
lated form of X31 HA from tunicamycin-treated HA-CHO, 
4J and 4B cells (Fig. 9, T). In infected HA-CHO cells, the 
core-glycosylated X31  HA synthesized during the 30-min 
pulse migrated with an apparent molecular mass of 80 kD 
(Fig. 9, lanes 3 and 6). During a 90-min chase, the X31 HA 
molecules were processed to the 82-kD terminally glycos- 
ylated form (Fig. 9, lanes 4 and 7). By contrast, infection of 
clones 4B and 4J with the X31 virus at 32 or 39°C resulted 
in the synthesis of up to eight HA species ranging in molecu- 
lar mass from 63 to 80 kD (Fig. 8).  Because only one HA 
species (61 kD) was synthesized in tunicamycin-treated  cells, 
the seven HA species correspond to HA polypeptides that 
differ in the number and/or composition of their N-linked 
oligosaccharide chains. The glycosylation  pattern of X31 HA 
in clones 4B and 4J varied with temperature. Seven distinct 
HA  species,  six  of them present  in  approximately equal 
amounts, were observed after synthesis at 39°C (Fig. 9, lanes 
13 and 20). However, at 32°C the predominant form of X31 
HA synthesized in the two mutant clones comigrated with the 
core-glycosylated species observed in infected parental HA- 
CHO cells and only minor amounts of the lower molecular 
mass species were present (Fig. 9, lanes 10 and 17). In other 
experiments, all eight HA species were present in approxi- 
mately equal amounts at 32°C (data not shown). The reason 
for this variation between experiments is unclear. It is possi- 
ble that the mutant cells are unable to transfer oligosaccha- 
rides to all seven attachment sites on X31 HA when the poly- 
peptide is synthesized at very high levels during the virus 
infection. This explanation is consistent with increased pro- 
portions of molecules bearing reduced numbers of side chains 
at 39°C, since more HA is synthesized at this temperature 
than at 32°C (Fig. 9). Variability between experiments per- 
formed at 32°C may be the result of differences in the level 
of synthesis of HA depending on the stage of the virus in- 
fection. 
The major change observed after a 90-min chase period 
was a decrease in the intensities of  the higher molecular mass 
HA bands and the appearance of an 82-kD species that mi- 
grated with a mobility slightly greater than that of terminally 
glycosylated X31 HA from infected HA-CHO cells (Fig. 9, 
lanes 11, 14,  18, and 2/).  The lower molecular mass HA 
species were present after a  90-min chase but in reduced 
amounts. Overall, there was significant turnover of the X31 
HA during the chase period at 39°C. 
VSV G glycoprotein was' also observed to be aberrantly 
glycosylated in clones 4B and 4J (Fig. 10). VSV G contains 
only two N-linked oligosaccharide chains and therefore only 
minor, but distinct, differences in the electrophoretic mobil- 
ity of  G protein may be noted in the experiment shown in Fig. 
10. The pattern of aberrant glycosylation in clone 4B and 4J 
cells appears similar to that seen with the endogenous HA. 
Thus the labeled G protein present after a  10-min pulse of 
the mutant cells at both 32 and 39°C migrated slightly faster 
on SDS-polyacrylamide gels than did the pulse-labeled G 
protein in the parental  HA-CHO cells.  Furthermore,  the 
more extensive terminal glycosylation  of  HA in clone 4J cells 
previously observed during the chase period at 32°C (Fig. 
8 A) was also apparent for G protein in clone 4B and 4J cells 
(Fig. 10). The incorrect glycosylation of G protein is almost 
certainly the reason for the significantly decreased yield of 
VSV from infected clone 4B and 4J cells (Table II). 
Finally, we have shown that the LDL receptor is aberrantly 
glycosylated and rapidly turned over in clone 4J cells (Fig. 
11). As has been described previously for the biosynthesis of 
the receptor in CHO cells (Tolleshaug et al., 1982),  we ob- 
served that after a 60-min pulse of parental HA-CHO ceils 
with [35S]methionine at 39°C, the labeled receptor migrated 
Hearing et al.  CHO Cell Secretory Pathway Mutants  349 Figure 9.  Synthesis and modification of X31 HA in HA-CHO cells and clones 4J and 4B. Cells were infected with X31 virus at 32 or 
39°C and the synthesis of X31 HA during a 20-min pulse with [35S]methionine  in the absence (P) or presence (T) of tunicamycin was 
examined as described in Materials and Methods. Some cultures were labeled for 20 min without tunicamycin and then chased in medium 
containing nonradioactive methionine for 90 min (C) before analysis. Uninfected HA-CHO cells (U) were also pulse-labeled for 20 min 
and immunoprecipitated with anti-X31 HA serum to demonstrate the specificity of this antibody and its lack of reactivity with the endoge- 
nous Japan HA. Lane 22 (M), ~4C molecular mass markers. 
on SDS-polyacrylamide gels as two bands of approximately 
equal intensity (Fig.  11). An •120-kD  species corresponds 
to the core-glycosylated form containing only N-linked oligo- 
saccharides, while an ~160-kD species corresponds to the 
terminally glycosylated form that also contains O-linked car- 
bohydrate side chains.  During a 2-h chase period at 39°C, 
all the labeled receptor was converted to the 160-kD form. 
However LDL receptor synthesized in clone 4J cells during 
the 60-min pulse at 39°C migrated aberrantly (Fig.  11). A 
diffuse band migrated slightly faster than the 120-kD species 
in the parental HA-CHO cells, and little or none of the 160- 
kD species was present. Instead, a broad band of evenly la- 
beled material migrated between  125-150 kD.  During the 
2-h chase period at 39°C, all the labeled receptor in the mu- 
tant cells was degraded. These results provide final confir- 
mation that the defect(s) in clone 4J and 4B cells lie in a cel- 
lular gene(s) that affects the glycosylation of a broad range 
of viral and cellular integral membrane glycoproteins. 
Discussion 
A  number of selection procedures have been developed to 
obtain mutant cell lines with defects in cellular components 
involved in the biosynthesis, processing,  and  intracellular 
transport of integral membrane glycoproteins. The majority 
of these procedures have involved the use of cytotoxic lectins 
to isolate stable, glycosylation-defective  mutants from a vari- 
ety  of  cultured  cell  types  (reviewed  by  Stanley,  1984, 
1987a,b).  Similar mutants have been isolated by screening 
for altered  sugar  incorporation  (Hirschberg  et  al.,  1981; 
Stanley,  1985), or by selecting against the cell-surface ex- 
pression of specific membrane glycoproteins such as Thy-1 
(Trowbridge and Hyman,  1975;  Trowbridge et al.,  1978), 
the  mannose-6-phosphate  receptor (Robbins  et  al.,  1981; 
Stoll et al.,  1982),  and the LDL receptor (Krieger et al., 
1981; Kingsley et al., 1986). 22 distinct glycosylation mutant 
types have now been classified that are affected at all stages 
of Asn-linked carbohydrate biosynthesis (reviewed by Stan- 
ley, 1987a,b). Unfortunately, very few mutants have been ob- 
tained that may be defective in components involved directly 
in protein transport rather than in glycoprotein processing 
(Nakano et al., 1985; Tufaro et al., 1987), and in neither of 
these instances has the specific defect been characterized. 
Furthermore, procedures designed to obtain mutants  with 
temperature-conditional  defects  in  the  secretory  pathway 
have only rarely been used and have yielded only one poten- 
tial candidate (Nakano et al.,  1985), raising the possibility 
that secretory pathway mutants with defects in genes whose 
products are essential for cell viability have not yet been ex- 
ploited fully. 
The novel selection procedure described in this paper used 
a cell line, HA-CHO, that stably expresses the HA glycopro- 
tein derived from the A/Japan/305/57 strain of influenza vi- 
rus (Sambrook et al., 1985). Flow cytofluorometry  was used 
to select from mutagenized HA-CHO cells a population of 
cells that  displayed temperature-conditional expression of 
HA on their plasma membranes. Cultures of mutant cells en- 
riched by multiple rounds of sorting were screened for clones 
exhibiting defects in the processing or intracellular transport 
of HA. Seven mutant cell lines were isolated and the majority 
of these clones also displayed impaired ability to support the 
propagation of VSV at the restrictive temperature, 39°C, in- 
dicating that the defective transport of HA to the plasma 
membrane was a consequence of a mutation in a gene encod- 
ing a necessary cellular component rather than the result of 
an alteration in the HA gene itself. This conclusion was sup- 
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CHO, clone 4B, and clone 4J cells. Cells were in- 
fected with VSV at 32 and 39°C as described in 
Materials and Methods. Cells were pulse-labeled 
for 10 min with [35S]methionine  and extracted im- 
mediately (P) or incubated 60 min in the presence 
of nonradioactive methionine (C). Uninfected (U) 
and  tunicamycin-treated (T)  VSV-infected HA- 
CHO cells were pulse-labeled for 10 min. VSV G 
protein was immunoprecipitated from cell extracts 
and examined by electrophoresis through 5-15% 
SDS-polyacrylamide gradient gels. Lane M,  t4C 
molecular mass markers. 
Figure 11. Synthesis of the LDL receptor in HA-CHO and clone 
4J cells. Cells were pulse-labeled for 60 min with [35S]methionine 
and extracted immediately (P) or incubated for a further 120 min 
in the presence of nonradioactive methionine (C), and then immu- 
nopreeipitated with anti-LDL receptor  serum and  analyzed by 
SDS-PAGE as described in Materials and Methods. Lane M,  ~4C 
molecular mass markers. 
ported by the observation that the molecular mass of the non- 
glycosylated form of HA synthesized in all the mutant cell 
lines in the presence of tunicamycin was identical to that in 
the parental HA-CHO cells.  The seven cell lines could be 
classified into two groups on the basis of the modification 
and fate of newly synthesized HA. The mutants of the first 
class exhibited temperature-sensitive defect(s) that resulted 
in reduced production or accelerated turnover of terminally 
glycosylated HA molecules. The mutants of the second class 
exhibited a nonconditional defect in core-glycosylation that 
resulted  in a  decreased  rate of terminal  glycosylation and 
intracellular  movement, although HA could still  be trans- 
ported to the plasma membrane.  However, the turnover of 
this abnormally modified HA was accelerated at 39°C result- 
ing in the temperature-conditional display of the protein on 
the cell surface. 
The first class of mutants includes five cell lines in which 
an apparently normal form of  core-glycosylated  HA was syn- 
thesized at both the permissive and restrictive temperatures. 
At 32°C, HA appeared to be processed normally and trans- 
ported to the cell surface. However, at the restrictive temper- 
ature, little  or no terminally glycosylated HA was observed 
although trimming of the mannose-rich side chains did oc- 
cur. A more detailed pulse-chase analysis of two of the mu- 
tants, clones 3A and 4E, revealed an accelerated rate of turn- 
over of intracellular HA in the mutant cells at 39°C. These 
five cell lines  are candidates for mutants carrying defects in 
components involved in protein transport. However,  we have 
not ruled out the possibility that a defect in oligosaccharide 
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degradation of HA. Two major issues concerning these mu- 
tants remain to be resolved. First, we would like to determine 
whether  membrane  or  secretory  proteins  synthesized  in 
these five cell lines are degraded at a staging point along the 
normal exocytotic pathway or diverted into a compartment 
where increased protein turnover occurs. Second, we would 
like to analyze the relationship between the five mutant cell 
lines, which appear to share a common phenotype despite 
having been isolated in four independent mutagenesis experi- 
ments. Determination of whether distinct underlying defects 
are present in these mutants will require more precise bio- 
chemical  characterization  and  analysis  by  genetic  com- 
plementation.  These experiments are currently underway. 
The two mutants of the second class,  clones 4B and 4J, 
differ from those of the first group in carrying mutations that 
affect core glycosylation at both permissive  and restrictive 
temperatures. In addition to the endogenously expressed Ja- 
pan HA, three other glycoproteins (X31 HA, VSV G, and the 
LDL receptor) were abnormally modified in these cell lines. 
Clones 4B and 4J are therefore members of the most com- 
mon group of secretory pathway mutants which are defective 
in the biosynthesis or processing of carbohydrate side chains 
(Stanley,  1984,  1987a,b).  We have characterized these two 
clones in some detail in this and the accompanying paper 
(Hearing et al.,  1989), and have found that both mutants ac- 
cumulate truncated lipid-linked oligosaccharide precursors 
of  the  structure  Man~GlcNAcz-P-P-dolichol  and  transfer 
both truncated and full length oligosaccharide chains to na- 
scent glycoproteins. The relationship between clones 4B and 
4J  and previously  described  mutants  that accumulate  the 
same precursor despite belonging to different complementa- 
tion groups (Stanley, 1984, 1987a) is discussed in the accom- 
panying  paper.  Although  the  truncated  oligosaccharides 
were  transferred  to nascent proteins at both 32  and 39°C 
(Hearing et al.,  1989), the extent of terminal glycosylation 
differed at the two temperatures. We do not yet know whether 
this  observation  reflects  a  greater  instability  of the more 
aberrantly modified molecules at the higher temperature, or 
a difference in the activity of the processing enzymes at the 
two temperatures  since HA in the parental HA-CHO cells 
also appeared to undergo less terminal glycosylation at 39°C. 
Structural analyses of isolated glycopeptides will be neces- 
sary to determine how the processing of the oligosaccharide 
side chains differs  between the two temperatures in the pa- 
rental and mutant cell lines. 
The selection scheme used in this work was designed to 
isolate cell mutants that were temperature conditional for the 
cell-surface expression of HA and other integral membrane 
proteins,  in the hope that we would obtain cell  lines with 
defects  in genes encoding components directly involved in 
protein transport.  Further characterization of our mutants 
should reveal the nature of their genetic defect(s) and provide 
valuable information about the mechanisms that control in- 
tracellular transport in mammalian cells. 
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